News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
634,749 Results
Type
Article (48716)
Company Profile (189)
Press Release (585828)
Multimedia
Podcasts (177)
Webinars (25)
Section
Business (173207)
Career Advice (2552)
Deals (32027)
Drug Delivery (157)
Drug Development (76726)
Employer Resources (167)
FDA (16602)
Job Trends (13387)
News (306997)
Policy (32127)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2403)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (156)
Alliances (43483)
ALS (191)
Alzheimer's disease (1813)
Antibody-drug conjugate (ADC) (389)
Approvals (16809)
Artificial intelligence (604)
Autoimmune disease (229)
Automation (40)
Bankruptcy (326)
Best Places to Work (9915)
BIOSECURE Act (23)
Biosimilars (215)
Biotechnology (97)
Bladder cancer (179)
Brain cancer (64)
Breast cancer (662)
Cancer (5190)
Cardiovascular disease (462)
Career advice (2166)
Career pathing (44)
CAR-T (284)
CDC (71)
Celiac Disease (1)
Cell therapy (803)
Cervical cancer (40)
Clinical research (66263)
Collaboration (1802)
Company closure (6)
Compensation (1280)
Complete response letters (90)
COVID-19 (2787)
CRISPR (97)
C-suite (958)
Cystic fibrosis (147)
Data (6761)
Decentralized trials (3)
Denatured (44)
Depression (172)
Dermatology (57)
Diabetes (536)
Diagnostics (5962)
Digital health (42)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (286)
Drug pricing (233)
Drug shortages (36)
Duchenne muscular dystrophy (278)
Earnings (73460)
Editorial (71)
Employer branding (20)
Employer resources (148)
Events (97775)
Executive appointments (1002)
FDA (20018)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1470)
Gene editing (213)
Generative AI (54)
Gene therapy (677)
GLP-1 (1151)
Government (4323)
Grass and pollen (8)
Guidances (390)
Healthcare (15591)
HIV (76)
Huntington's disease (56)
IgA nephropathy (94)
Immunology and inflammation (316)
Immuno-oncology (83)
Indications (151)
Infectious disease (3097)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (122)
Intellectual property (265)
Interviews (469)
IPO (15234)
IRA (59)
Job creations (3777)
Job search strategy (1776)
JPM (73)
Kidney cancer (19)
Labor market (92)
Layoffs (633)
Leadership (45)
Legal (7771)
Liver cancer (99)
Longevity (25)
Lung cancer (699)
Lymphoma (396)
Machine learning (48)
Management (55)
Manufacturing (912)
MASH (185)
Medical device (11887)
Medtech (11954)
Mergers & acquisitions (17916)
Metabolic disorders (1497)
mRNA (205)
Multiple sclerosis (164)
NASH (24)
Neurodegenerative disease (400)
Neuropsychiatric disorders (113)
Neuroscience (3232)
Neurotech (2)
NextGen: Class of 2026 (5291)
Non-profit (3359)
Now hiring (44)
Obesity (751)
Opinion (319)
Ovarian cancer (170)
Pain (228)
Pancreatic cancer (250)
Parkinson's disease (347)
Partnered (29)
Patents (549)
Patient recruitment (571)
Peanut (59)
People (53017)
Pharmaceutical (76)
Pharmacy benefit managers (34)
Phase 1 (19944)
Phase 2 (28838)
Phase 3 (22843)
Pipeline (6913)
Policy (362)
Postmarket research (2553)
Preclinical (8247)
Press Release (48)
Prostate cancer (280)
Psychedelics (59)
Radiopharmaceuticals (289)
Rare diseases (1060)
Real estate (5257)
Recruiting (69)
Regulatory (25118)
Reports (45)
Research institute (2263)
Resumes & cover letters (420)
Rett syndrome (32)
RNA editing (19)
RSV (83)
Schizophrenia (173)
Series A (255)
Series B (188)
Service/supplier (9)
Sickle cell disease (109)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (50)
Startups (3296)
State (2)
Stomach cancer (21)
Supply chain (123)
Tariffs (101)
The Weekly (130)
Vaccines (1161)
Venture capital (106)
Weight loss (522)
Women's health (96)
Worklife (23)
Date
Today (144)
Last 7 days (698)
Last 30 days (2683)
Last 365 days (29463)
2026 (7762)
2025 (29692)
2024 (33272)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39200)
2018 (29903)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (777)
Alabama (74)
Alaska (7)
Arizona (271)
Arkansas (12)
Asia (38948)
Australia (6362)
California (11712)
Canada (3020)
China (1184)
Colorado (491)
Connecticut (529)
Delaware (354)
Europe (89525)
Florida (1792)
Georgia (362)
Hawaii (4)
Idaho (43)
Illinois (871)
India (78)
Indiana (492)
Iowa (22)
Japan (486)
Kansas (116)
Kentucky (43)
Louisiana (32)
Maine (75)
Maryland (1432)
Massachusetts (8472)
Michigan (291)
Minnesota (607)
Mississippi (5)
Missouri (127)
Montana (18)
Nebraska (26)
Nevada (124)
New Hampshire (68)
New Jersey (3192)
New Mexico (17)
New York (3050)
North Carolina (1534)
North Dakota (7)
Northern California (5841)
Ohio (321)
Oklahoma (19)
Oregon (37)
Pennsylvania (2278)
Puerto Rico (19)
Rhode Island (34)
South America (1147)
South Carolina (73)
South Dakota (1)
Southern California (4606)
Tennessee (179)
Texas (1781)
United States (41173)
Utah (295)
Virginia (288)
Washington D.C. (77)
Washington State (914)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
634,749 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
Press Releases
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
April 1, 2026
·
4 min read
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
Gilead continues its dealmaking spree in the sizzling hot space of I&I as Johnson & Johnson, along with partner Protagonist, notched an FDA approval for a new psoriasis drug. Plus, Aurinia Pharmaceuticals gets a new C-suite, FDA releases draft guidance on non-animal models and the CDC’s vaccine advisory committee is not being disbanded after all.
March 25, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential
April 1, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - March 12, 2026
March 13, 2026
·
3 min read
Press Releases
Acumen Pharmaceuticals to Showcase Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 3, 2026
·
7 min read
Press Releases
NBDF’s Pathway to Cures Announces Spark Biomedical’s LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding
March 25, 2026
·
4 min read
Podcast
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
Heath Secretary Robert F. Kennedy Jr.’s efforts to overhaul vaccine policy are likely illegal, a Massachusetts District Court Judge ruled; Structure’s GLP-1 weight loss pill succeeds in Phase 2 while Rhythm’s Phase 3 basket trial fails to find the beat; Eli Lilly warns of potential safety risks of taking compounded tirzepatide, and Novo Nordisk is hit with an FDA warning letter regarding adverse events potentially linked to Ozempic.
March 18, 2026
·
1 min read
·
Heather McKenzie
1 of 63,475
Next
